Urinary Tract Infection (UTI) Test

The advanced UTI testing solution that quickly provides personalized therapy options

The UTI test combines advanced PCR technology with proprietary susceptibility testing to deliver personalized antibiotic options in less than 48 hours

Precision Pathogen Identification

PCR identifies 27 uropathogens and 
3 resistance markers

Whole Specimen Susceptibility

In vitro susceptibility results for 21 antibiotics directly from patient sample 

Rapid Results

Fast, personalized results reported
within 48 hours 

Urinary tract infections (UTIs) are among the most common infections, accounting for more than 10 million office visits and 3 million emergency department visits, at an estimated annual cost burden of US$3.5 billion in the U.S.1,2

Timely and accurate pathogen identification and antimicrobial susceptibility testing are critical for optimal patient management. However, urine culture, which has been standard of care, may fail to provide physicians with enough information to make informed and timely decisions. Urine culture has been shown to miss up to 67% of organisms,especially in polymicrobial infections, and results may take 3-5 days. As a result, clinicians treat patients empirically, which has contributed to the rise of multi-drug resistant organisms, reduced treatment options, and increased costs.

There are better, more advanced UTI diagnostic tools available. In fact, literature has shown that tests that combine PCR identification of uropathogens and resistance genes, along with antibiotic susceptibility testing, have been associated with better patient outcomes.4

Mdxhealth is proud to offer a UTI test that utilizes molecular PCR technology for the identification of infectious agents and resistance genes, along with antimicrobial susceptibility testing to address the patient’s specific infection. The assay identifies common uropathogens and resistance genes, and then it tests those pathogens’ susceptibility against a panel of antibiotics.

By combining the molecular identification of common uropathogens and resistance genes, along with a unique, whole-urine susceptibility method, advanced UTI tests help clinicians improve UTI management by providing personalized antibiotic options in an easy-to-read report.

Contact a Local Representative

Questions about our tests or ready to set up a new account?

  1. Foxman B, et al. The Epidemiology of Urinary Tract Infection. Nat Rev Urol 2010; 7: 653-60.
  2. Flores-Mireles AL, et al. Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options. Rev Microbiol 2015; 13: 269-84.
  3. Sathiananthamoorthy S, Malone-Lee J, Gill K, et al. Reassessment of Routine Midstream Culture in Diagnosis of Urinary Tract Infection. J Clin Microbiol. 2019;57(3):e01452-18. Published 2019 Feb 27. doi:10.1128/JCM.01452-18.
  4. Annemarie D, David B, Kelly R, Natalie L, Meghan C, et al. Utilization of M-PCR and P-AST for Diagnosis and Management of Urinary Tract Infections in Home-Based Primary Care. JOJ Urology & Nephrology, 2020; 7(2): 555707. DOI: 10.19080/JOJUN.2020.07.555707